Market Research Report

The US Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack)
cover Published by Venture Planning Group
Published Product code 246839
Price

Introduction

Abstract

Description

This report provides:

  • Five-year sales forecasts for the US Molecular Diagnostics market, including:
    • Infectious Diseases
    • Cancer
    • Forensic Testing
    • Genetic Diseases
    • Paternity Testing/HLA Typing, and other applications.
  • Sales forecasts for HIV, Hepatitis (A, B, C), Parvovirus B19 and West Nile Virus.
  • Sales and market shares for major suppliers of molecular diagnostics and NAT assays.

Table of Contents

Table of Contents

List of Tables

  • Table 1. U.S.A.: Molecular Diagnostics Market by Major Application
  • Table 2. U.S.A.: Infectious Disease Blood Screening NAT Reagent Market by Assay
  • Table 3. U.S.A.: Molecular Diagnostics Market, Estimated Sales and Shares of Major Suppliers
  • Table 4. U.S.A.: HIV/Hepatitis Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers
  • Table 5. U.S.A.: West Nile Virus Blood Screening NAT Market, Estimated Sales and Shares of Major Suppliers

The US Molecular Diagnostics and NAT Market: Sales Forecasts and Key Supplier Shares (DataPack) published by Venture Planning Group in July 16, 2012. This report price starts from US $ 1500.

Back to Top